Association between HSP90 and Her2 in gastric and gastroesophageal carcinomas.
<h4>Background</h4>Her2 expression and amplification occurs in a significant subset of gastro-esophageal carcinomas. Her2 is a client protein of molecular chaperones, e.g. heat shock protein (HSP) 90, rendering targeted therapies against Her2/HSP90 an interesting approach. This study aim...
Main Authors: | Sabina Berezowska, Alexander Novotny, Karina Bauer, Annette Feuchtinger, Julia Slotta-Huspenina, Karen Becker, Rupert Langer, Axel Walch |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23874879/pdf/?tool=EBI |
Similar Items
-
Heat Shock Protein 90 (HSP90) and Her2 in Adenocarcinomas of the Esophagus
by: Julia Slotta-Huspenina, et al.
Published: (2014-06-01) -
Clinical significance of NOTCH1 and NOTCH2 expression in gastric carcinomas: an immunohistochemical study
by: Lukas eBauer, et al.
Published: (2015-04-01) -
UICC Staging after Neoadjuvant/Perioperative Chemotherapy Reveals No Significant Survival Differences Compared to Primary Surgery for Locally Advanced Gastric Cancer
by: Rebekka Dimpel, et al.
Published: (2022-12-01) -
Significance of Lauren Classification in Patients Undergoing Neoadjuvant/Perioperative Chemotherapy for Locally Advanced Gastric or Gastroesophageal Junction Cancers—Analysis from a Large Single Center Cohort in Germany
by: Rebekka Schirren, et al.
Published: (2021-01-01) -
Significance of tumour regression in lymph node metastases of gastric and gastro‐oesophageal junction adenocarcinomas
by: Daniel Reim, et al.
Published: (2020-10-01)